JP2010030903A5 - - Google Patents

Download PDF

Info

Publication number
JP2010030903A5
JP2010030903A5 JP2008165187A JP2008165187A JP2010030903A5 JP 2010030903 A5 JP2010030903 A5 JP 2010030903A5 JP 2008165187 A JP2008165187 A JP 2008165187A JP 2008165187 A JP2008165187 A JP 2008165187A JP 2010030903 A5 JP2010030903 A5 JP 2010030903A5
Authority
JP
Japan
Prior art keywords
solid preparation
calcium silicate
tranexamic acid
solid
preparation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008165187A
Other languages
Japanese (ja)
Other versions
JP2010030903A (en
JP5475254B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2008165187A priority Critical patent/JP5475254B2/en
Priority claimed from JP2008165187A external-priority patent/JP5475254B2/en
Publication of JP2010030903A publication Critical patent/JP2010030903A/en
Publication of JP2010030903A5 publication Critical patent/JP2010030903A5/ja
Application granted granted Critical
Publication of JP5475254B2 publication Critical patent/JP5475254B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (4)

イブプロフェン及びトラネキサム酸を含有する固形製剤であって、
ケイ酸カルシウムを含有することを特徴とする固形製剤。 A solid formulation containing ibuprofen and tranexamic acid,
A solid preparation containing calcium silicate. ケイ酸カルシウムが固形製剤全体に対して０．０１〜５０質量％である請求項１記載の固形製剤。   The solid preparation according to claim 1, wherein the calcium silicate is 0.01 to 50 mass% with respect to the whole solid preparation. 剤形が錠剤である請求項１又は２記載の固形製剤。   The solid preparation according to claim 1 or 2, wherein the dosage form is a tablet. イブプロフェン及びトラネキサム酸を含有する固形製剤を製造する方法であって、ケイ酸カルシウムを添加する工程、
を含むことを特徴とする製造方法。 A method for producing a solid preparation containing ibuprofen and tranexamic acid, comprising adding calcium silicate,
The manufacturing method characterized by including.
JP2008165187A 2007-06-25 2008-06-25 Solid formulation containing ibuprofen, tranexamic acid and calcium silicate Active JP5475254B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008165187A JP5475254B2 (en) 2007-06-25 2008-06-25 Solid formulation containing ibuprofen, tranexamic acid and calcium silicate

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2007165869 2007-06-25
JP2007165869 2007-06-25
JP2008163942 2008-06-24
JP2008163942 2008-06-24
JP2008165187A JP5475254B2 (en) 2007-06-25 2008-06-25 Solid formulation containing ibuprofen, tranexamic acid and calcium silicate

Publications (3)

Publication Number Publication Date
JP2010030903A JP2010030903A (en) 2010-02-12
JP2010030903A5 true JP2010030903A5 (en) 2011-04-07
JP5475254B2 JP5475254B2 (en) 2014-04-16

Family

ID=41735855

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008165187A Active JP5475254B2 (en) 2007-06-25 2008-06-25 Solid formulation containing ibuprofen, tranexamic acid and calcium silicate

Country Status (1)

Country Link
JP (1) JP5475254B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013031935A1 (en) * 2011-08-31 2013-03-07 興和株式会社 Stable pharmaceutical composition
JP7130481B2 (en) * 2017-07-18 2022-09-05 アリナミン製薬株式会社 film coated tablets

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04253922A (en) * 1991-02-05 1992-09-09 Tokuyama Soda Co Ltd Sustained release preparation
JP3667381B2 (en) * 1995-03-27 2005-07-06 株式会社資生堂 Antipyretic analgesic
JP4717414B2 (en) * 2004-11-08 2011-07-06 富田製薬株式会社 Low melting point drug-containing granule and tablet produced using the same

Similar Documents

Publication Publication Date Title
CL2013001586A1 (en) Rapid dispersion microgranular composition comprising at least one sugar alcohol, a saccharide, or a mixture thereof, at least one super disintegrant and at least one multifunctional additive; oral disintegration tablet comprising the microgranular composition and at least one active ingredient; and manufacturing methods.
JP2013510216A5 (en)
JP2015525757A5 (en)
JP2011506530A5 (en)
JP2012126725A5 (en)
JP2009524697A5 (en)
JP2012255026A5 (en)
JP2013525444A5 (en)
JP2011124545A5 (en)
JP2014521659A5 (en)
JP2012502876A5 (en)
JP2015526577A5 (en)
JP2014520090A5 (en)
JP2013005790A5 (en)
JP2010209099A5 (en)
JP2012512815A5 (en)
JP2006342148A5 (en)
JP2012516348A5 (en)
JP2012204605A5 (en)
WO2012074830A3 (en) Modified release tranexamic acid formulation
JP2008280345A5 (en)
JP2010030903A5 (en)
JP2013536814A5 (en)
JP2011063849A5 (en)
JP2013245137A5 (en)